Delivery Order SPE2DB25D3108-SPE2DB25FPDJM
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,204.42 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector units on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy medication delivered via auto-injector,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 100 mg/0.5 mL XYOSTED auto-injectors. The $1,309.95 order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of January 16, 2024. This delivery order was placed under an existing indefinite delivery contract between AmerisourceBergen Drug Corp and DLA to...
- The Defense Logistics Agency awarded a delivery order valued at $1,308.93 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector units on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product administered via auto-injector, supporting the Defense Health...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,006 to Amerisourcebergen Drug Corporation for the supply of 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone replacement drug. The single day order is to be fulfilled from Amerisourcebergen's distribution center in Conshohocken, Pennsylvania under the parent company Amerisourcebergen Corporation's federal supply schedule contract with the DLA. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a delivery order valued at $1,524.90 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector supplies on July 18, 2025, with completion targeted for July 21, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on capability. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery order. This delivery order...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563188562 - XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceuticals. The $1,458.01 delivery order has a completion date of December 28, 2023 and was awarded on December 27, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contract awards from DLA Troop...
- The Defense Logistics Agency awarded a $3,155.07 delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector medication, with performance scheduled for completion by July 22, 2025. This non-competitive delivery order represents a firm fixed price contract executed on July 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,727 to Amerisourcebergen Drug Corporation for the supply of 50 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone replacement drug. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in mid-July 2023. Amerisourcebergen Corporation is the identified parent company. No subcontractors or set aside designations were indicated. This order...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,240 to Amerisourcebergen Drug Corporation for XYOSTED 100 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the injectable testosterone replacement therapy products to a location in Conshohocken, Pennsylvania by July 10, 2023 to support DLA requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which...
- The Defense Logistics Agency awarded a $306 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561521698 XYOSTED 75 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the 0.5mL auto-injectable testosterone cypionate product to a location in Conshohocken, Pennsylvania by July 18, 2023 to support Defense Logistics Agency requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation,...